Clinical Trial Update: Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study. [Phase 4]

View source ↗

Summary

Phase 4 multicenter randomized trial comparing mycophenolate sodium versus mycophenolate mofetil to assess dose optimization and potential tacrolimus dose reduc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Mycophenolate sodium (mycophenolate sodium)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft | Phase 4 | Status: COMPLETED | Results posted: 2014-12-03